Logo image of SMED

SHARPS COMPLIANCE CORP (SMED) Stock Price, Quote, News and Overview

NASDAQ:SMED - Nasdaq - US8200171010 - Common Stock - Currency: USD

8.75  +0.01 (+0.11%)

SMED Quote, Performance and Key Statistics

SHARPS COMPLIANCE CORP

NASDAQ:SMED (8/22/2022, 8:00:03 PM)

8.75

+0.01 (+0.11%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High9.66
52 Week Low2.83
Market Cap170.01M
Shares19.43M
Float16.07M
Yearly DividendN/A
Dividend YieldN/A
PE46.05
Fwd PE100.92
Earnings (Next)09-13 2022-09-13/bmo
IPO02-02 1994-02-02


SMED short term performance overview.The bars show the price performance of SMED in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

SMED long term performance overview.The bars show the price performance of SMED in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6

The current stock price of SMED is 8.75 USD. In the past month the price increased by 1.39%. In the past year, price decreased by -7.99%.

SHARPS COMPLIANCE CORP / SMED Daily stock chart

SMED Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 11.03 82.59B
CVS CVS HEALTH CORP 11.74 80.09B
LH LABCORP HOLDINGS INC 17.36 21.10B
DGX QUEST DIAGNOSTICS INC 19.47 19.50B
FMS FRESENIUS MEDICAL CARE-ADR 13.87 13.67B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 147.98 12.11B
DVA DAVITA INC 14.99 11.68B
HIMS HIMS & HERS HEALTH INC 109.98 10.57B
CHE CHEMED CORP 24 8.24B
CRVL CORVEL CORP 25.89 5.56B
OPCH OPTION CARE HEALTH INC 26.82 5.43B
GH GUARDANT HEALTH INC N/A 5.37B

About SMED

Company Profile

Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. The company is headquartered in Houston, Texas and currently employs 190 full-time employees. The firm's services includes medical, pharmaceutical and hazardous for small and medium quantity generators. The firm's lead products are the Sharps Recovery System and MedSafe Medication Disposal System. The Sharps Recovery System is a comprehensive medical waste management mailback solution used in all markets due to its availability. The MedSafe solution meets the immediate needs of an increasing community risk associated with unused, ultimate-user, medications. The firm also offers its route-based pick-up services in approximately 37 state regions of the South, Southeast, Southwest, Midwest and Northeast portions of the United States.

Company Info

SHARPS COMPLIANCE CORP

Ste 500, 9220 Kirby Drive

Houston TEXAS 77054 US

CEO: David P. Tusa

Employees: 190

Phone: 17134320300.0

SHARPS COMPLIANCE CORP / SMED FAQ

What is the stock price of SHARPS COMPLIANCE CORP today?

The current stock price of SMED is 8.75 USD. The price increased by 0.11% in the last trading session.


What is the ticker symbol for SHARPS COMPLIANCE CORP stock?

The exchange symbol of SHARPS COMPLIANCE CORP is SMED and it is listed on the Nasdaq exchange.


On which exchange is SMED stock listed?

SMED stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SHARPS COMPLIANCE CORP stock?

9 analysts have analysed SMED and the average price target is 7.52 USD. This implies a price decrease of -14.03% is expected in the next year compared to the current price of 8.75. Check the SHARPS COMPLIANCE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SHARPS COMPLIANCE CORP worth?

SHARPS COMPLIANCE CORP (SMED) has a market capitalization of 170.01M USD. This makes SMED a Micro Cap stock.


How many employees does SHARPS COMPLIANCE CORP have?

SHARPS COMPLIANCE CORP (SMED) currently has 190 employees.


What are the support and resistance levels for SHARPS COMPLIANCE CORP (SMED) stock?

SHARPS COMPLIANCE CORP (SMED) has a support level at 8.71 and a resistance level at 8.76. Check the full technical report for a detailed analysis of SMED support and resistance levels.


Is SHARPS COMPLIANCE CORP (SMED) expected to grow?

The Revenue of SHARPS COMPLIANCE CORP (SMED) is expected to decline by -19.46% in the next year. Check the estimates tab for more information on the SMED EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SHARPS COMPLIANCE CORP (SMED) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SHARPS COMPLIANCE CORP (SMED) stock pay dividends?

SMED does not pay a dividend.


When does SHARPS COMPLIANCE CORP (SMED) report earnings?

SHARPS COMPLIANCE CORP (SMED) will report earnings on 2022-09-13, before the market open.


What is the Price/Earnings (PE) ratio of SHARPS COMPLIANCE CORP (SMED)?

The PE ratio for SHARPS COMPLIANCE CORP (SMED) is 46.05. This is based on the reported non-GAAP earnings per share of 0.19 and the current share price of 8.75 USD. Check the full fundamental report for a full analysis of the valuation metrics for SMED.


SMED Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to SMED. When comparing the yearly performance of all stocks, SMED is one of the better performing stocks in the market, outperforming 98.19% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SMED Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to SMED. SMED has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SMED Financial Highlights

Over the last trailing twelve months SMED reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -67.24% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.25%
ROA 2.89%
ROE 4.19%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%-102.5%
Sales Q2Q%-36.15%
EPS 1Y (TTM)-67.24%
Revenue 1Y (TTM)18.16%

SMED Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 49% to SMED. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of -96.71% and a revenue growth -19.46% for SMED


Ownership
Inst Owners1.02%
Ins Owners8.93%
Short Float %N/A
Short RatioN/A
Analysts
Analysts48.89
Price Target7.52 (-14.06%)
EPS Next Y-96.71%
Revenue Next Year-19.46%